ArticleMedicine2015

Somatostatin Receptor SSTR-2a Expression Is a Stronger Predictor for Survival Than Ki-67 in Pancreatic Neuroendocrine Tumors.

Shreya Mehta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.